Tab Article
"Diagnosis, risk stratification, selection of therapy, interim/post-therapy evaluation by MRD/PET-CT-based investigations, and subsequent modification of the therapeutic procedure have transformed the overall outcome of hematological malignancies. Molecular investigations are a requirement at all stages: Diagnosis, risk stratification, interim/MRD evaluation, etc. Matched unrelated donor/Haplo Allo BMT has enhanced the possibility of Allo BMT in most of the patients as a curative option. This first joint venture ICH-ICP e-Monogram, highlighting the above points, is primarily meant for postgraduates."
Priyanka
Verified PurchaseI am a first year student pursuing MBBS. I am really grateful to medioks for being student oriented. I was looking for a book but I couldn't find it anywhere in the market. The high demand of the book made it very costly to afford online but when I found it on medioks, I was so happy to get? the original book at a reasonable cost.